93364-66-0 Usage
Molecular Structure
Contains a thiadiazole ring, two amine groups, a phenylmethyl group, and a pyridinyl group
Target Enzyme
Glycogen synthase kinase-3 (GSK-3)
Inhibition
Potent and selective inhibitor of GSK-3
Cellular Processes
Regulates cell survival, proliferation, and differentiation
Therapeutic Applications
Potential use in treating Alzheimer's disease, diabetes, and cancer
Anti-Inflammatory Properties
Exhibits anti-inflammatory effects in preclinical studies
Neuroprotective Properties
Demonstrates neuroprotective effects in preclinical studies
Anti-Cancer Properties
Shows potential anti-cancer properties in preclinical studies
Regenerative Medicine
Explored for its potential use in promoting cell proliferation and survival in tissue engineering
Further Research
Additional studies needed to fully understand the benefits and risks of using TDZD-8 for therapeutic purposes
Check Digit Verification of cas no
The CAS Registry Mumber 93364-66-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,3,6 and 4 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 93364-66:
(7*9)+(6*3)+(5*3)+(4*6)+(3*4)+(2*6)+(1*6)=150
150 % 10 = 0
So 93364-66-0 is a valid CAS Registry Number.
93364-66-0Relevant academic research and scientific papers
2-(2-Pyridylaminoalkylamino)-4-pyrimidones
-
, (2008/06/13)
Pyridine derivatives are disclosed which are useful as histamine H1 -antagonists.